Internal Medicine | Page 263 of 487 | Links Medicus Content Curation & Alerts in Medicine

No #SARSCoV2 vaccine has yet to be shown to be effective or safe.
Effective = it prevents infections.
Safe = it doesn't engender serious adverse effects.https://t.co/dsyk8m6pEx @NatureMedicine
Please keep this in mind now that @US_FDA's @SteveFDA has lost all credibility pic.twitter.com/OgQIpDPv6R

— Eric Topol (@EricTopol) August 24, 2020

First Covid-19 reinfection documented in Hong Kong

25 Aug, 2020 | 04:00h | UTC

First Covid-19 reinfection documented in Hong Kong, researchers say – STAT

Commentaries: Some people can get the pandemic virus twice, a study suggests. That is no reason to panic – Science AND You can get reinfected with Covid-19 but still have immunity. Let’s explain – Vox AND Expert reaction to first reported case of COVID-19 re-infection in Hong Kong patient – Science Media Centre

Commentary on Twitter

In Hong Kong, researchers reported what appears to be the first confirmed case of Covid-19 reinfection in a 33-year-old man. The virus sequenced from his two infections didn't match, indicating the second one was not tied to the first. https://t.co/4GHd1lMRZ0

— STAT (@statnews) August 24, 2020

FDA issues emergency use authorization for convalescent plasma as potential COVID–19 treatment

25 Aug, 2020 | 03:58h | UTC

FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic – U.S. Food & Drug Administration

Commentaries: Convalescent Plasma: The Science and the Politics – Science Translational Medicine AND Convalescent plasma: another controversial clash of politics & science – Health News Review AND Observational Study of Convalescent Plasma and FDA Response – datamethods AND FDA OKs use of convalescent plasma for COVID-1 – CIDRAP AND Is convalescent plasma safe and effective? We answer the major questions about the Covid-19 treatment – STAT

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19

25 Aug, 2020 | 03:53h | UTC

Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19 – Canadian Medical Association Journal

An inflammatory cytokine signature predicts COVID-19 severity and survival

25 Aug, 2020 | 03:57h | UTC

An inflammatory cytokine signature predicts COVID-19 severity and survival – Nature

Commentary: Researchers discover immune predictors of COVID-19 cases that fare the worst – The Mount Sinai Hospital

Commentary on Twitter

Elevated levels of serum IL-6 and TNF-α at the time of hospitalization are independent and significant predictors of clinical outcome in two cohorts of patients with #COVID19 #biomarker @IcahnMountSinai @SinaiImmunol @TischCancer @MiriamMerad https://t.co/syHWT6QaW0

— Nature Medicine (@NatureMedicine) August 24, 2020

Not just antibodies: B cells and T cells mediate immunity to COVID-19

25 Aug, 2020 | 03:54h | UTC

Not just antibodies: B cells and T cells mediate immunity to COVID-19 – Nature Reviews Immunology

Commentary on Twitter

Concise and useful summary of the B and T cell response to #COVID19 https://t.co/RQ2ABn8CYf @NatRevImmunol pic.twitter.com/Bk9IiJFfwQ

— Eric Topol (@EricTopol) August 24, 2020

Cost of contact: Redesigning healthcare in the age of COVID

25 Aug, 2020 | 03:51h | UTC

Cost of contact: redesigning healthcare in the age of COVID – BMJ Quality & Safety

Commentary on Twitter

The ‘cost of contact’ associated with risks of COVID-19 is forcing redesign of healthcare. That may be a good thing. say @sacha_bhatia, @kgshojania and Wendy Levinson, but it needs to be done well. https://t.co/cq5gYtuvMT

— BMJ Quality & Safety (@BMJ_Qual_Saf) August 24, 2020

The disappearance of the primary care physical examination—losing touch

25 Aug, 2020 | 03:49h | UTC

The Disappearance of the Primary Care Physical Examination—Losing Touch – JAMA Internal Medicine (free for a limited period)

Meta-analysis: Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients

25 Aug, 2020 | 03:40h | UTC

Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials – Intensive Care Medicine

Podcast: Hypertension in the Hospital

25 Aug, 2020 | 03:38h | UTC

Annals On Call – Hypertension in the Hospital – Annals of Internal Medicine

Commentary on Twitter

Listen to the latest #AnnalsOnCall with @medrants, Dr Timothy Anderson, and @WrayCharles on #Hypertension in the Hospital https://t.co/OouHuYg0wt. pic.twitter.com/CbJyq7wyDq

— Annals of Int Med (@AnnalsofIM) August 24, 2020

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

25 Aug, 2020 | 03:45h | UTC

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients – PLOS One

The neuroleptic malignant syndrome—a systematic case series analysis focusing on therapy regimes and outcome

25 Aug, 2020 | 03:37h | UTC

The neuroleptic malignant syndrome—a systematic case series analysis focusing on therapy regimes and outcome – Acta Psychiatrica Scandinavica

Commentary: Treating Neuroleptic Malignant Syndrome: A Case Series – NEJM Journal Watch

Randomized trial: Remdesivir vs. standard care in patients with moderate COVID-19

24 Aug, 2020 | 00:53h | UTC

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Efficacy of Remdesivir in COVID-19

Commentaries: Study: Remdesivir doesn’t boost outcomes in moderate pneumonia from COVID-19 – UPI AND New Remdesivir Study Shows the Trouble With Bad Science – The Wire

Commentary on Twitter

Remdesivir….good editorial, concludes we don't know who to give it to, nor for how long, nor if it improves outcomes, nor whether, if it does, it does that beyond what dexamethasone or other corticosteroids do. https://t.co/Qi1dTSPcYi

— Dr. Tom Frieden (@DrTomFrieden) August 21, 2020